THERAPiN
Cannabis-based Drug Preparations
StartupTHERAPiN is a Ramot Menashe-based startup in the Health Tech & Life Sciences sector, established in 2017. Cannabis-based Drug Preparations. The company has raised a total of $22M across 2 funding rounds, currently at the A stage. Key investors include Undisclosed Investor(s). The company has 1-10 employees. Core technologies: Biologicals, Herbals, Materials & Substances, Raw Materials.
With $22M in total funding, THERAPiN is a A-stage company operating in Health Tech & Life Sciences. The company follows a B2C/B2B business model. Product stage: Released.
- StageA
- ProductReleased
- ModelB2C, B2B
- Employees1-10
- HQRamot Menashe
- DistrictNorth District
- Last Round$10M
- Undisclosed Investor(s)
What does THERAPiN do?
THERAPiN develops, grows, and produces raw materials and premium cannabis products for medical and cosmetic use for the international market.
How much funding has THERAPiN raised?
THERAPiN has raised $22M in total funding across 2 rounds. The company is currently at the A stage. Key investors include Undisclosed Investor(s).
What sector is THERAPiN in?
THERAPiN operates in Health Tech & Life Sciences, Pharma & Medical Biotechnology, Cosmetic Materials, Medical Cannabis, with core technologies in Biologicals, Herbals, Materials & Substances, Raw Materials. Target customers: Healthcare & Life Sciences, Life Sciences, Pharmaceuticals, Cosmetics, Consumers, Recreational & Lifestyle, Cannabis.
Where is THERAPiN located?
THERAPiN is based in Ramot Menashe, Israel, North District.